PATH

A promotional image for a report titled "Health R&D Financing in Africa: Towards Resilience, Innovation, and Sovereignty." The image includes a download button and displays three pages of the report with text and images. The logo for PATH appears at the bottom.

📣 A new policy brief from PATH & @impactglobalhealth.bsky.social outlines pathways to strengthen sustainable, country-led health R&D ecosystems in Africa.

A must-read for policymakers, funders, and advocates shaping Africa’s innovation future: https://bit.ly/4sojdfo

#HealthPolicy #GlobalHealth

Promotional graphic reads, "Regulatory pathways for combination vaccines are evolving. WHO and PATH convened experts to explore how current regulatory strategies could be updated to facilitate the licensure pathway. #CombinationVaccines." The background is blue with abstract line designs connecting icons of a vaccine vial, a clipboard, and two people. Logos for PATH and the World Health Organization are at the bottom right corner.

Last year, PATH and @who.int convened vaccine experts, public health officials, and regulators to explore new ways to facilitate approval of novel #CombinationVaccines.

These insights are now published in Vaccine: https://bit.ly/4r52Ovm

#VaccinesWork @elsevierhms.bsky.social

In a landmark moment for #CervicalCancer prevention, India has just introduced HPV vaccination on a single-dose schedule.

1 in 5 cervical cancer deaths occur in India. This vaccine will save many lives. #VaccinesWork

https://bit.ly/4l4aiNR

Promotional image for PATH's Excel-based vaccine cost calculators designed for middle-income countries. It highlights tools for pneumococcal conjugate vaccine, rotavirus vaccine, and human papillomavirus vaccine, with availability in French and Spanish. Several colorful graphs and charts are displayed.

We just expanded our suite of redesigned and upgraded Vaccine Cost Calculators specifically for middle-income countries to include a tool that supports #HPV vaccine decision-making.

Learn more: https://bit.ly/4bT8qoD

#VaccinesWork

Wild Poliovirus Transmission Persists In Afghanistan And Pakistan - Health Policy Watch The report warns that progress toward eradication remains fragile. Some 38 cases of wild poliovirus type 1 had been reported globally by 22 October 2025, down

🦠 Polio cases are down globally — but transmission persists in Afghanistan & Pakistan.

Vaccine-derived outbreaks remain active in 13 countries.

Eradication is within reach — but only with sustained political will & stronger immunization systems.🌍

✍️ @ibukhariarsalan.bsky.social
@gavi.org
📖⬇️ & 🔁🙏

Infographic titled 'Snapshot of CEPI 3.0' displaying a circular flowchart divided into three sections: Integrated viral family approach to vaccine development; Ready-to-activate networks and capabilities; Vaccine platforms are ready and available. Central text reads: 'Impact: Saving lives quickly, reducing risk, and making innovation accessible.'

Epidemics & pandemics are a defining #HealthSecurity challenge of our time. @cepi.net is working to transform the way we tackle today’s viral threats and get ahead of tomorrow’s.

CEPI's 3.0 strategy aims to secure a safer, better prepared future for all: https://bit.ly/4cFE2y9

#SecureTheFuture

PATH and CEPI team members are seated in a conference room for a simulation exercise to test the design and development of the Biospecimen Sourcing Initiative. Overlaid text reads: "With help from PATH, CEPI’s Biospecimen Sourcing Initiative aims to create a faster, easier, more equitable system for collecting biological samples in an outbreak"

The Biospecimen Sourcing Initiative aims to facilitate the timely and ethical collection of biological samples during an outbreak: https://bit.ly/4qILZWZ

Biospecimens from survivors are necessary for the rapid development of new vaccines, treatments & diagnostics.

#100DaysMission @cepi.net

Dr. Melanie Saville, Chief Scientific Officer at PATH

Prof. Bilal Mateen, Chief AI Officer at PATH

Two PATH leaders have been recognized at the highest levels of #GlobalHealth policy:

Melanie Saville ➡️ Chair, @who.int Product Development for Vaccines Advisory Committee

Bilal Mateen ➡️ Member, UN Independent International Scientific Panel on AI

Congrats, Mel & Bilal! https://bit.ly/3OCZWYZ

A person working in a laboratory is adjusting equipment on a table filled with scientific instruments. A text overlay reads "This month in PATH Insights: 3 game-changing health innovations," with the subtitle "Creating affordable health products that actually work in low-resource settings." A subscribe button appears underneath the text.

This month in PATH Insights, we're highlighting our medical devices and health technologies program!

🧪💡 Explore a few of the PATH innovations making an impact worldwide.

Read now & subscribe: https://bit.ly/43WBrtU

#HealthInnovation #HealthTech

This image is an infographic about respiratory syncytial virus (RSV). It highlights the impact of RSV, noting 33 million episodes of severe respiratory infection, 3.6 million pediatric hospitalizations, and 101,000 deaths, primarily affecting infants under 6 months. The infographic emphasizes available tools like maternal vaccines and monoclonal antibodies to combat RSV.

#RSV has long put infants at risk of severe respiratory disease—but with maternal vaccines and monoclonal antibodies, we have new ways to fight it.

📣 Help spread the word with our social media tools: https://bit.ly/4aTn9yF

#RSVAwareness #RSVVW26

A laptop displays a spreadsheet for a vaccine cost calculator. On the right, the text reads: "Human papillomavirus vaccine cost calculator for middle-income countries. An Excel-based tool with simple user inputs to inform product decision-making for HPV immunization programs. Also available in French and Spanish." The PATH logo is visible.

📢 New resource now available for middle-income countries—check out our #HPV Vaccine Cost Calculator to compare products and estimate vaccination program costs for different vaccine options.

⏩ https://bit.ly/469b99D

#VaccinesWork #HealthEconomics

Maternal vaccines and monoclonal antibodies are powerful new tools to protect children from respiratory syncytial virus (#RSV).

Join PATH at #RSVVW26 this week, and check out our resources to spread the word about RSV prevention: https://bit.ly/4rqGPQz

AI therapy is booming — Seattle is helping set the guardrails Companies would need to show evidence that their tools actually improve mental health outcomes.

PATH is helping South African regulators develop a framework to evaluate AI #MentalHealth tools. “You wouldn’t give your child a drug that hadn’t been tested or evaluated for safety,” PATH's Bilal Mateen explains. The same rigor should apply to AI.

More from @axios.com: https://bit.ly/409r3gN

CEPI launches global plan to secure the future against epidemic and pandemic threats The new five-year strategy—CEPI 3.0—was unveiled today as CEPI called on governments, philanthropies and partners to invest US$2.5 billion to strengthen the world’s disease defences.

Today marks the launch of the CEPI 3.0 Investment Case and Strategy.

CEPI 3.0 – our 2027-2031 strategy - is the next step in CEPI’s mission to transform the way the world tackles epidemic and pandemic threats.

Discover more in the press release ⬇️

This image contains a stylized illustration of a person. At the top, the United Nations logo is visible, followed by the name "Bilal Mateen." Below, the text reads: "Member of the Independent International Scientific Panel on AI."

Congrats to PATH Chief AI Officer Bilal Mateen on his appointment to the UN Independent International Scientific Panel on #AI. 🎉

Bilal brings clinical & frontline health care expertise to the 40-person panel, which will assess the real-world impacts of AI.

@unodet.bsky.social @unesco.org

Africa at the crossroads: Why African-led R&D is more important than ever At CPHIA 2025, PATH and Impact Global Health convened a high-level discussion on why Africa must invest boldly and consistently in its own health R&D ecosystem to secure resilience, equity, and long-t...

Over 90% of medicines and diagnostics used in Africa are currently imported, leaving the region vulnerable to supply shocks. Strengthening regional R&D ecosystems and manufacturing capabilities is a strategic imperative for health security. ⏩ https://bit.ly/4a8XujX

#MadeInAfrica #HealthSovereignty

A promotional poster for a webinar titled "Maximizing malaria vaccine visits within routine immunization platforms: Early insights and opportunities." It is scheduled for February 25 at 8:30am EST, 1:30pm GMT, 3:30pm CAT. The background is red and blue with images of health care workers and children.

How can routine immunization platforms help maximize #malaria vaccine visits? Join PATH and @gavi.org on February 25 for a webinar presenting lessons learned from Mozambique and Burkina Faso.

✍️ Register now: https://bit.ly/4riVInl

#EndMalaria #VaccinesWork

#JustPublished in @nathealth.nature.com: the results of our LLM benchmarking study in Rwanda, funded by Gates in partnership w/ Digital Umuganda, Rwanda Centre for the Fourth Industrial Revolution, Rwanda Biomedical Centre & @unibirmingham.bsky.social.

👉 https://go.nature.com/3ZUFCom

#AIForHealth

How PATH advances women's health worldwide Seattle global health organization has a keen focus on women and children

How does PATH improve health for women and children? Formidable speaks with Chief Global Health Programs Officer Kammerle Schneider: https://beformidable.com/p/how-path-advances-women-s-health-worldwide

#WomensHealth #HealthForAll

Improving HIV assisted partner services outcomes by eliciting additional partners after the initial encounter Most assisted partner services (APS) programs elicit partners at the time of HIV diagnosis when index clients may be reluctant to name all partners. Little is known about the benefits of ongoing partn...

New research from @path.org and @uwdgh.bsky.social:

New evidence from Kenya: continuing assisted partner services beyond HIV diagnosis identifies far more new HIV cases—partners named later were ~4× more likely to be newly diagnosed.

journals.plos.org/globalpublic...

Innovation in action: Pioneering injectable rotavirus vaccines A bold scientific effort to reimagine rotavirus vaccination is leaving a lasting legacy—and opening new doors for innovation.

With support from the Gates Foundation, PATH and partners have been working for nearly 15 years to develop an injectable #rotavirus vaccine.

While the candidate we tested was unsuccessful, this bold scientific effort to reimagine rotavirus vaccination leaves a lasting legacy: https://bit.ly/3ZGMuFH

An open letter ahead of the 158th WHO Executive Board and 79th World Health Assembly | Transform Health From 15 senior leaders of global health organisations: We need concrete commitments on health data governance at the World Health Assembly ____________ Dear WHO Member States and delegates to the 158t...

The @who.int Executive Board meeting begins today, and we're calling for action on stronger #HealthDataGovernance.

PATH joins 14 other #GlobalHealth orgs calling on WHO Member States to make concrete commitments to ensure health data is governed ethically, safely & fairly: https://bit.ly/4rqfg9k

Being a Good Ancestor: The Legacy of Dr. Bill Foege (1936–2026) YouTube video by Becoming Better Ancestors

Becoming Better Ancestors, a learning series featuring our founder Dr. William Foege, shared a moving tribute in his honor. Watch now: www.youtube.com/watch?v=s6d5... #BillFoege #BecomingBetterAncestors #9Lessons #GlobalHealth

For the January edition of PATH Insights, we spotlight some of the #GlobalHealth wins of 2025—and the PATH staff, partners, and supporters who made progress possible in a tumultuous year.

Read now & subscribe: https://bit.ly/43WBrtU

#PublicHealthSky

Strengthening integrated disease surveillance: The bedrock of health systems Across South Asia, robust, integrated disease surveillance is vital for preventing, detecting, and managing infectious disease outbreaks. Uttar Pradesh’s response to Acute Encephalitis Syndrome (AES) ...

On #WorldNTDDay, our focus must include the systems that detect & respond to outbreaks.

In India, Uttar Pradesh’s approach to Acute Encephalitis Syndrome shows how integrated disease surveillance can strengthen #GlobalHealthSecurity.

https://bit.ly/3LLqDK9

🌐 #WorldNTDDay 🌐

On January 30, World Neglected Tropical Diseases Day, Chagas Coalition joins the global community in recognizing the millions of people living with these 21 diseases that affect more than 1 billion people in the world 🫂

💪 #UniteActEliminate

#BeatNTDs #NTDs
#DíaMundialDeLasETD

📢 Today is #WorldNTDDay!

Over 1B people are affected by neglected tropical diseases. Too many still lack safe & effective treatments.

👉 Share this post to support science, innovation & global health funding. #EndTheNeglect #BeatNTDs #UniteActEliminate

New study validates previous conclusions supporting a single-dose HPV vaccination schedule Findings demonstrate non-inferiority of one dose compared to two doses of HPV vaccines to prevent cervical cancer-causing HPV infections.

Results from the first blinded, randomized non-inferiority trial assessing one vs. two doses of HPV vaccine find each schedule is 97% effective. It is the latest addition to the evidence in support of @who.int’s 2022 single-dose recommendation: https://bit.ly/4qNIaAq

#CervicalCancer #VaccinesWork

Nonprofit of the Month: PATH For more than four decades, PATH has worked at the intersection of science, innovation, and equity to expand access to quality health care.

PATH is Fabulous Washington's #nonprofit of the month! Check out the Q&A with our Chief Global Health Programs Officer Kammerle Schneider: https://fabulouswashington.com/philanthropy/nonprofit-of-the-month-path/

#GlobalHealth #HealthEquity

Gallery of Global Health Game Changers: How US investments in global health R&D are saving lives globally and delivering at home GHTC hosted an event on Capitol Hill inviting congressional staffers, agency and administration officials, and the broader global health community to see, touch, taste, and discover how more than 25 U...

US investment & ingenuity are fueling innovations to fight deadly health threats—saving lives globally & benefiting Americans. We brought 25+ US-backed tools to the Hill that are saving lives, lowering costs, and preventing future pandemics. #Innovate4Health

www.ghtcoalition.org/blog/gallery...